PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA ends

Transcription–replication conflicts underlie sensitivity to PARP inhibitors

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy